Metoprolol vs Atenolol: Nutrient Depletion Comparison
Compare YOUR medications' depletionsFree, 10 seconds →
At a Glance
Metoprolol selectively blocks beta-1 adrenergic receptors, reducing heart rate and cardiac output. Beta-1 blockade suppresses the sympathetic nervous system's stimulation of pineal melatonin synthesis — the pineal gland relies on beta-1 receptor activation to produce melatonin at night. Metoprolol's lipophilic structure allows it to cross the blood-brain barrier freely, reaching the pineal gland at high concentrations and creating more aggressive melatonin suppression than hydrophilic beta-blockers. CTD documents gene interactions affecting both adrenergic signaling and mitochondrial CoQ10-dependent electron transport.
Metoprolol has 38% oral bioavailability due to extensive first-pass CYP2D6 metabolism, with a short 3.6-hour half-life requiring twice-daily dosing (or extended-release for once-daily). CYP2D6 poor metabolizers experience dramatically higher drug levels.
- ✓Proven mortality reduction in heart failure (MERIT-HF trial, 3,991 patients)
- ✓Extended-release formulation (succinate) allows once-daily dosing despite short half-life
- ✓Lipophilic properties provide better anxiolytic effects through CNS penetration
- ✓PharmGKB Level 1A evidence for CYP2D6 pharmacogenomic dosing guidance
- ✗Lipophilic CNS penetration causes more vivid dreams, nightmares, and sleep disruption from melatonin suppression
- ✗CYP2D6-dependent metabolism creates significant drug interaction risks and genetic variability in blood levels
- ✗38% bioavailability means most of the drug is lost to first-pass metabolism — unpredictable in CYP2D6 poor metabolizers
- ✗Short 3.6-hour half-life (IR form) requires strict twice-daily timing
Heart failure patients (per MERIT-HF evidence), those with performance anxiety benefiting from CNS effects, and patients who can use CYP2D6 pharmacogenomic testing to guide dosing.
Atenolol blocks the same beta-1 receptors but its hydrophilic (water-soluble) structure limits blood-brain barrier penetration. This means atenolol suppresses melatonin less aggressively than metoprolol because it reaches the pineal gland at lower concentrations. However, peripheral beta-1 blockade still reduces the sympathetic drive to melatonin synthesis, so some melatonin suppression occurs. CoQ10 depletion happens through the same mechanism as metoprolol — reduced mitochondrial energy production through beta-adrenergic pathway modulation.
Atenolol achieves 58% oral bioavailability without CYP metabolism — it's renally eliminated unchanged, meaning no CYP2D6 drug interactions and consistent blood levels regardless of genetic polymorphisms. Half-life is 6.1 hours allowing once-daily dosing.
- ✓Hydrophilic structure causes fewer CNS side effects — less insomnia, fewer nightmares, less vivid dreaming
- ✓No CYP450 metabolism — eliminated renally unchanged, eliminating drug interaction complexity
- ✓Higher bioavailability (58% vs 38%) provides more consistent blood levels without genetic variability
- ✓Once-daily dosing with 6.1-hour half-life simplifies adherence
- ✗Less proven heart failure mortality benefit compared to metoprolol succinate's MERIT-HF evidence
- ✗ASCOT-BPLA trial raised concerns about atenolol-based regimens for cardiovascular outcomes vs newer agents
- ✗Renal elimination means dose adjustment required in kidney disease — impaired patients accumulate the drug
- ✗Still depletes melatonin peripherally even without strong CNS penetration — sleep disruption still possible
Patients who experience insomnia or nightmares on lipophilic beta-blockers, those with multiple CYP2D6-metabolized medications, or patients who need a beta-blocker without CNS side effects.
Feature Comparison
| Feature | Metoprolol | Atenolol |
|---|---|---|
| Drug Class | Beta-1 selective blocker (lipophilic) | Beta-1 selective blocker (hydrophilic) |
| Nutrients Depleted | 2 — CoQ10, melatonin | 2 — CoQ10, melatonin |
| Bioavailability | 38% (CYP2D6-dependent) | 58% (renal, no CYP) |
| Half-Life | 3.6 hours (IR) / 12h (XR) | 6.1 hours |
| CNS Penetration | High (lipophilic — crosses BBB) | Low (hydrophilic — limited BBB crossing) |
| Melatonin Suppression | More aggressive (CNS + peripheral) | Less aggressive (primarily peripheral) |
| Metabolism | CYP2D6 hepatic (genetic variability) | Renal elimination (no CYP) |
| HF Mortality Evidence | MERIT-HF (3,991 patients) | Limited direct evidence |
Wondering which medication depletes less?
Check your medications free — 10 seconds →Verdict
Both beta-blockers deplete the same two nutrients — CoQ10 and melatonin — through beta-1 receptor blockade, and both benefit from the same supplementation protocol. The critical differentiator is CNS access. Metoprolol's lipophilic structure crosses the blood-brain barrier freely, creating more aggressive pineal melatonin suppression that causes insomnia, vivid dreams, and nightmares — the most common reason patients abandon beta-blocker therapy. Atenolol's hydrophilic structure limits CNS penetration, causing less melatonin disruption and fewer sleep-related side effects. For heart failure, metoprolol succinate has MERIT-HF mortality data that atenolol lacks. For hypertension with sleep concerns, atenolol's CNS-sparing profile and CYP-free metabolism make it the gentler choice. Either way, CoQ10 100 mg ubiquinol and melatonin 0.3–0.5 mg at bedtime address the complete two-nutrient depletion burden.
FAQ
References
- [1]MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure. Lancet. 1999;353(9169):2001-2007
- [2]CTD (Comparative Toxicogenomics Database): gene interactions for both drugs affecting beta-adrenergic and melatonin synthesis pathways
- [3]FAERS (FDA Adverse Event Reporting System): safety reports for both metoprolol and atenolol across cardiovascular indications
- [4]PharmGKB pharmacogenomics database: CYP2D6 Level 1A evidence for metoprolol dosing; renal elimination annotations for atenolol
- [5]PubMed PMID 10789600 — Stoschitzky K et al. Influence of beta-blockers on melatonin release. Eur J Clin Pharmacol. 1999;55(2):111-115
Check your medications
Check Free →